🇺🇸 FDA
Patent

US 6939847

Use of colostrinin, constituent peptides thereof, and analogs thereof, as oxidative stress regulators

expired A61KA61K38/07A61K38/08

Quick answer

US patent 6939847 (Use of colostrinin, constituent peptides thereof, and analogs thereof, as oxidative stress regulators) held by The Board of Regents of the University of Texas System expires Mon Sep 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Sep 06 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K38/07, A61K38/08, A61K38/10, A61K38/17